1. Long-Term Follow-Up of High-Risk Breast Lesions at Vacuum-Assisted Biopsy without Subsequent Surgical Resection
- Author
-
Elfgen, Constanze; https://orcid.org/0000-0001-6092-6612, Varga, Zsuzsanna; https://orcid.org/0000-0002-2855-983X, Breitling, Katrin, Pauli, Eliane, Schwegler-Guggemos, Daniela, Kampmann, Gert, Kubik-Huch, Rahel A; https://orcid.org/0000-0002-3636-8697, Leo, Cornelia; https://orcid.org/0000-0003-1601-0281, Lepori, Domenico, Sonnenschein, Martin, Tausch, Christoph, Schrading, Simone, Elfgen, Constanze; https://orcid.org/0000-0001-6092-6612, Varga, Zsuzsanna; https://orcid.org/0000-0002-2855-983X, Breitling, Katrin, Pauli, Eliane, Schwegler-Guggemos, Daniela, Kampmann, Gert, Kubik-Huch, Rahel A; https://orcid.org/0000-0002-3636-8697, Leo, Cornelia; https://orcid.org/0000-0003-1601-0281, Lepori, Domenico, Sonnenschein, Martin, Tausch, Christoph, and Schrading, Simone
- Abstract
INTRODUCTION B3-lesions of the breast are a heterogeneous group of neoplasms, associated with a higher risk of breast cancer. Recent studies show a low upgrade rate into malignancy after subsequent open surgical excision (OE) of most B3-lesions when proven by vacuum-assisted biopsy (VAB). However, there is a lack of long-term follow-up data after VAB of high-risk lesions. The primary aim of this study was to demonstrate whether follow-up of B3 lesions is a beneficial and reliable alternative to OE in terms of long-term outcome. The secondary aim was to identify patient and lesion characteristics of B3 lesions for which OE is still necessary. METHODS This retrospective multicenter study was conducted at 8 Swiss breast centers between 2010 and 2019. A total of 278 women (mean age: 53.5 ± 10.7 years) with 286 B3-lesions who had observation only and who had at least 24 months of follow-up were included. Any event during follow-up (ductal carcinoma in situ [DCIS], invasive cancer, new B3-lesion) was systematically recorded. Data from women who had an event during follow-up were compared with those who did not. The results for the different B3 lesions were analyzed using the t test and Fisher's exact test. A p value of <0.05 was considered statistically significant. RESULTS The median follow-up interval was 59 months (range: 24-143 months) with 52% (148/286) having a follow-up of more than 5 years. During follow-up, in 42 women, 44 suspicious lesions occurred, with 36.4% (16/44) being invasive cancer and 6.8% (3/44) being DCIS. Thus, 6.6% (19/286) of all women developed malignancy during follow-up after a median follow-up interval of 6.5 years (range: 31-119 months). The initial histology of the B3 lesion influenced the subsequent occurrence of a malignant lesion during follow-up (p < 0.038). The highest malignancy-developing rate was observed in atypical ductal hyperplasia (ADH) (24%, 19/79), while all other B3-lesions had malignant findings ipsi- and contralateral betwe
- Published
- 2024